Westport
Westport
Westport, Connecticut, United States9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain | Back Pain, Low Back Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vertebrogenic Pain Syndrome | Recruiting | Not stated | 2026-10-09 | NCT06827262 | |
| A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows | Moderate to Severe Glabellar Lines | Active, not recruiting | Phase 3 | 2026-10-01 | NCT07435428 | |
| A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States | Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Cholinergic Agents; Membrane Transport Modulators; Molecular Mechanisms of Pharmacological Action; Neuromuscular Agents; Neurotransmitter Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; incobotulinumtoxinA | Active, not recruiting | Phase 3 | 2026-09-10 | NCT07122193 | |
| Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region | Chin Augmentation | Recruiting | Not applicable | 2026-08-14 | NCT07566286 | |
| Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds | Nasolabial Folds | Active, not recruiting | Not applicable | 2026-07-21 | NCT06984835 | |
| Stem Cell Ophthalmology Treatment Study II | Abnormalities, Multiple, CNS demyelinating autoimmune disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Injuries, Craniocerebral Trauma, Deaf-Blind Disorders, Deafness, Doyne honeycomb retinal dystrophy, Ear Diseases, Eye Diseases, Hereditary, Geographic Atrophy, Hearing Loss, Sensorineural, Leber hereditary optic neuropathy, Neurologic Manifestations, Nutritional and Metabolic Diseases, Optic Atrophy, Autosomal Dominant, Optic Neuropathy, Ischemic, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Stargardt disease, Usher syndrome, Vision, Low, acute transverse myelitis, age-related macular degeneration, autoimmune disease, autoimmune disorder of the nervous system, blindness (disorder), cardiovascular disorder, cone dystrophy, cone-rod dystrophy, cranial nerve neuropathy, demyelinating disease, eye disorder, glaucoma, hearing disorder, hearing loss disorder, hereditary disease, hereditary optic atrophy, immune system disorder, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, inherited retinal dystrophy, injury, macular degeneration, metabolic disease, nervous system disorder, nervous system injury, neurodegenerative disease, neuromyelitis optica, nutritional deficiency disease, nutritional disorder, ocular hypertension, optic atrophy, optic nerve disorder, optic neuritis, otorhinolaryngologic disease, retinal degeneration, retinal disorder, retinitis pigmentosa, traumatic optic neuropathy, vascular disorder, vision disorder, vitamin A deficiency, vitamin deficiency disorder, wet macular degeneration | Recruiting | Not applicable | 2026-06-29 | NCT03011541 | |
| Neurologic Stem Cell Treatment Study | Alzheimer disease, Brain Damage, Chronic, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Cerebral Small Vessel Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocerebral Trauma, Diabetes Complications, Disease Attributes, Frontotemporal Lobar Degeneration, Hemorrhage, Infarction, Intracranial Hemorrhages, Lewy Body Variant of Alzheimer Disease, Lewy body dementia, Necrosis, Nerve Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autonomic nervous system disorder, basal ganglia disorder, brain disorder, brain infarction, brain injury, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, cranial nerve neuropathy, dementia, dementia pugilistica, demyelinating disease, diabetes mellitus, diabetic neuropathy, endocrine system disorder, eye disorder, frontotemporal dementia, hereditary disease, hypotensive disorder, immune system disorder, injury, intracerebral hemorrhage, intracranial arterial disease, ischemic disease, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, multiple system atrophy, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, peripheral nervous system disorder, peripheral neuropathy, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, stroke disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-06-26 | NCT02795052 | |
| A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars | Acne Scars | Recruiting | Phase 3 | 2025-11-24 | NCT07207369 | |
| Study to Evaluate the Safety and Effectiveness of GP0116 | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations | Active, not recruiting | Not applicable | 2025-07-02 | NCT05987163 |